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OPINION OF THE COMMISSION 
pursuant to Article 189 b (2) (d) of  the EC Treaty, 
on the European Parliament's amendment 
to the Council's common position regarding the 
proposal for a 
EUROPEAN PARLIAMENT AND COUNCIL DECISION 
adopting a programme of  Community action 1999-2003 on rare diseases in the 
context of  the framework for action in the field of public health, 
AMENDING THE PROPOSAL OF THE COMMISSION 
pursuant to Article 189 a (2) of  the EC Treaty OPINION OF THE COMMISSION 
pursuant to Article 189 b (2) (d) of  the EC Treaty, 
on the European Parliament's amendment 
to the Council's common position regarding the 
proposal for a 
EUROPEAN PARLIAMENT AND COUNCIL DECISION 
adopting a programme of  Community action 1999-2003 on rare diseases in the 
context of  the framework for action in the field of public health, 
(1)  The initial  proposal  for  a  European Parliament and Council  decision adopting a 
programme of  Community action on rare diseases was adopted by the Commission 
on 26 May 1997
1
• 
(2)  The Economic and Social Committee
2 and the Committee of  the Regions
3 delivered 
favourable opinions on this initial Commission proposal. 
(3)  In the  light of the  European Parliament's opinion after its  first  reading on  lO-
ll  March 1998 the Commission, in accordance with article 189a (2) of the treaty, 
submitted an amended proposal for a decision
4
• This text incorporated amendments 
that clarified and broadened the actions covered by the programme. 
(4)  The European Parliament (first reading) had adopted twenty-eight amendments of 
which sixteen could be accepted by the Commission: one in toto, two with slight 
rewording and thirteen partially (matched with a modified proposition). 
(5)  The twelve  amendments  which were  not acceptable by  the  Commission can be 
grouped as follows: 
six concerned the recitals in the preamble; 
five concerned the articles of  the decision; 
one concerned the annex; 
The reasons for rejecting these twelve amendments were the following: 
- four amendments were not acceptable for legal reasons (n° 6, 10, 20, 21); 
- one amendment fell outside the scope of  the programme (n° 18) 
- three amendments were unacceptably limiting (n° 4, 15, 24) 
- two amendments were covered elsewhere (n° 11, 13) 
- two amendments were unacceptable due to budgetary limitations (n° 14, 19). 
(6)  The  Council  of Ministers  on  30  April  1998  unanimously  reached  a  Common 
Position
5
•  The  Commission,  in  view  of the  second  reading  by  the  European 
Parliament, reserved its position, with particular reference to the following aspects: 
as  regards  the  comitology  procedure  (article  5),  the  provision  of a  mixed 
management-advisory committee, as  opposed to the advisory committee proposed 
by the Commission and supported by the Parliament, is likely to be excessive and 
inappropriate  in  the  context  of the  programme,  considering  its  limited  budget 
allocation;  furthermore  the  Commission  reserved  its  position  in  respect  to  the 
Parliament's amendments (first reading) accepted· (fully or partially) in its amended 
C)  OJ N°C 203 of03.07.97 
~)  OJN°C 19of21.1.98 
e)  OJ N°C 64 of27.2.98 
(
4
)  OJ N° C 160 of27.5.9S 
( 5)  OJ N° C 227 of20.7.98 proposal  but not taken up  by  the Council.  The  Council accepted  in its  Common 
Position seven EP amendments: n° 2,  3 and 14 in toto; n° 7, 16, 22 and 23 partially; 
the Council did not accept twenty-one EP amendments: n°  1, 4, 5, 6, 8, 9, 10, 11, 12, 
13, 15, 17, 18, 19, 20, 21, 24, 25, 26,27 and  28. 
(7)  On 8'h  October  1998, the  European Parliament (second reading)  adopted twenty 
amendments to the common position 
Of  these  twenty  amendments: 
nine concern the recitals in the preamble 
seven concern the articles of the decision ( one concerns comitology and 
one concerns budget) 
four concern the annex (detail and content of  the actions) 
(8)  The opinion of the Commission concerning each of these amendments is given in 
the annex. Eleven amendments are acceptable,. of which three in toto (n° 3, 12, 16) 
and eight partially (n° 1, 6, 7, 9, 11, 15, 17, 19). 
Nine amendments are considered unacceptable: 
- n° 4, 8, 13 for legal reasons; 
- n° 5, 20 for internal consistency;  ~ 
- n° 2, 10 because unacceptably limiting; 
- n° 18 because covered elsewhere; 
- n° 14 for budgetary reasons. 
(9)  The Commission points out that in accordance with article 189b(3) of  the Treaty if, 
within three months of receiving the Parliament amendments, the Council, acting 
by  a  qualified  majority,  approves  all  of the  amendments,  it  shall  amend  its 
Common position accordingly and adopt the act in question; however, the Council 
shall act unanimously on the amendments on which the Commission has delivered 
a  negative  opinion.  If the  Council  does  not  approve  the  act  in  question,  the 
President  of the  Council,  in  agreement  with  the  President  of the  European 
Parliament, shall forthwith convene a meeting of  the Conciliation Committee.  · ANNEX 
Amendment 1: Commission opinion: partially acceptable. 
The amendment is acceptable with the following formulation: 
"whereas Community actions should be  directed towards the  prevention of diseases  and 
whereas action by the Community can provide unique added value to tackling problems, 
the  scale of which in individual countries is too small to allow the necessary analysis or 
proper action;". 
Amendment 2: Commission opinion: unacceptable. 
This amendment is not appropriate, as it stresses the causation mechanism in the definition 
of  rare diseases; the causation mechanism for many of  them is unknown  .. The amendement 
is unacceptably limiting. 
Amendment 3: Commission opinion: acceptable. 
Amendment 4: Commission opinion: unacceptable. 
This amendment is  not  in line  with the  wording  of article  129  of the  EC  Treaty;  it  is 
unacceptable for legal reasons. 
Amendment 5: Commission opinion: unacceptable. 
The provision of  a Community databank contradicts amendment 17, which is acceptable on 
this point. For this reason, the amendment is unacceptable for internal consistency. 
Amendment 6: Commission opinion: partially acceptable. 
Patients and health professionals could be stressed with the following wording: " ... of all 
involved, in particular health professionals, patients' and support group associations". 
Amendment 7: Commission opinion: partially acceptable, 
The  amendment  is  acceptable  with  the  following  formulation:  "whereas  the  Council 
resolution on equality  of opportunity  for  people with disabilities  of 20 December  1996 
invites  to  promote  the  involvement  of representatives  of people with  disabilities  in the 
implementation and follow-up of  relevant policies and actions in their favour." 
Amendment 8: Commission opinion: unacceptable. 
This amendment is not in line with the wording of  article 129 of  the EC; it is unacceptable 
for legal reasons. 
Amendment 9: Commission opinion: partially acceptable. 
Research is not covered by  this programme proposal.  The first  part of the  amendment 
finishing at "under the programme" can be acceptable. 
Amendment 10: Commission opinion: unacceptable, 
See  amendment  2.  This  amendment  is  not  appropriate,  as  it  stresses  the  causation 
mechanism in the definition of  rare diseases; the causation mechanism for many of  them is 
unknown  .. The amendement is unacceptably limiting. Amendment 11: Commission opinion: partially acceptable. 
The  amendment  is  acceptable  with  the  following  formulation:  The  wording  "and 
strengthening national and international" should be replaced by "transnational": this would 
better implement the principles of  Community added value and of  subsidiarity; the wording 
. "in particular patient self-help and relatives' groups" should be deleted, as it could refer to 
actions beyond the capacity of  the programme. 
Amendment 12: Commission opinion: acceptable. 
Amendment 13: Commission opinion: unacceptable 
This amendment is not in line with previous decisions for the European Parliament and the 
· Council on other public health programmes. It is not acceptable for legal reasons. 
Amendment 14: Commission opinion: unacceptable. 
This amendment is not acceptable for budgetary reasons: current financial perspectives do 
not allow a financial envelope ofECU 14 million for the period 1999-2003. 
Amendment 15: Commission opinion: partially acceptable. 
The  Commission  agrees  with  Parliament  as  regards  the  preference  for  an  advisory 
Commi~ee rather than a mixed advisory-management Committee. The provision of two 
representatives, one to be drawn from  voluntary organisations, is not in keeping with the 
wording of the  "Comitology" decision (Council Decision of 13  July  1987). This part is 
unacceptable for legal reasons. 
Amendment 16: Commission opinion: acceptable. 
Amendment 17: Commission opinion: partially acceptable. 
This amendment is acceptable with the following formulation: after "the condition.", the 
text to  be  accepted  should  stop with the  phrase:  "this  information should be  made  as 
widely available as possible". 
Amendment 18: Commission opinion: unacceptable 
The provision for training is covered elsewhere: annex, action 7 of Commission proposals 
and 4 of  Common Position. 
Amendment 19: Commission opinion: partially acceptable. 
This amendment is acceptable with the following formulation:  "promote collaboration and 
networking  between  groups  of persons  directly  or  indirectly  affected  by the  same  rare 
conditions or volunteers and professionals involved and coordination at Community level in 
order to encourage continuity of  work and trans-national cooperation;" 
Amendment 20: Commission opinion: unacceptable 
The wording "rapid response systems" is not consistent with the provision of  article 1, and 
disproportionate  in the  context of the  programme.  The  amendment  is  unacceptable  for 
internal consistency. ~ED  PROPOSAL 
FOR A EUROPEAN PARLIAMENT AND COUNCIL DECISION 
ADOPTING A PROGRAMME OF COMMUNITY ACTION 1999-2003 ON RARE 
DISEASES IN THE CONTEXT OF THE FRAMEWORK FOR ACTION IN THE FIELD 
OF PUBLIC HEALTH, COUNCIL COMMON POSITION 
DECISION No  /98/EC OF THE 
EUROPEAN PARLIAMENT AND OF 
THE COUNCIL 
Of 
Adopting a programme of  Community action 
On rare diseases within the framework for 
action 
in the field of  public health 
(I  999 to 2003) 
THE EUROPEAN PARLIAMENT AND 
THE COUNCIL OF THE EUROPEAN 
UNION, 
Having regard to the Treaty establishing the 
European Community, and in particular 
Article 129 thereof, 
Having regard to the proposal from the 
Commission <•>, 
Having regard to the Opinion of  the Economic 
and Social Committee <
2>, 
Having regard to the Opinion of  the Committee 
of  the Regions !3>, 
Acting  in accordance  with  the  procedure  laid 
down in Article 189b of  the Treaty <
4>, 
OJ C 203,  3.7.1997, p. 6. 
OJ C  19, 21.1.1998, p. 4. 
OJ C 64, 27.2.1998, p. 96 
AMENDED PROPOSAL 
(0)  Whereas  Community  actions  should  be 
directed towards the· prevention of diseases and 
whereas action by the Community can provide 
unique  added value  to  tackling  problems,  the 
scale  of which  in  individual  countries  is  too 





(4)  Opinion of  the European Parliament of  11  March 1998 (not yet published in the Official Journal), 
Council Common Position of  (not yet published in the Official Journal) and Decision of 
the European Parliament of  (not yet published in the Official Journal). (1)  Whereas,  for  the  purposes  of  this 
programme,  rare  diseases  are 
life-threatening  or  chronically 
debilitating  diseases  which  are  of such 
low  prevalence  that  special  combined 
efforts are needed to address them so as 
to prevent significant perinatal and early 
morbidity or mortality or a considerable 
reduction  in  an  individual's  quality  of 
life or socio-economic potential; 
(2)  Whereas, as a guide, low prevalence can 
be  understood  as  meaning  prevalence 
which  is  generally  recognized  as 
less than 5  per 10 000  in  the 
Community; 
(3)  Whereas  the  very  fact  of the  rarity  of 
low-prevalence  diseases  and  conditions 
and the  lack of information about them 
may mean that people  affected by  such 
diseases  and  conditions  do  not  benefit 
from  the  health  resources  and  services 
which they need; 
(4)  Whereas  the number of people affected 
by  individual  rare  diseases  is, 
by definition,  -:relatively  small  in 
comparison  with  more  commonplace 
disorders;  whereas,  however,  these 
diseases  taken  together  are  quite 
prevalent  and  affect  a  significant 
percentage of  the general population; 
(5)  Whereas rare diseases are considered to 
have little impact on society as a whole 
owing  to  their  low  prevalence 
individually;  whereas,  however,  they 
pose  serious  difficulties  for  ~ufferers 
and their families; 
(6)  Whereas, in accordance with Article 3(o) 
of the Treaty,  Community activities  are 
to  include  a  contribution  to  the 
attainment  of  a  high  level  of health 
. protection; 
(Sa)  Whereas  understanding  of rare  diseases 
needs  to  be  improved,  since  they  constitute 
warning signs from a public health perspective 
to  the  extent that problems  shown to  affect  a 
small  section of the population could,  as  time 
passed, spread to the community as a whole if 
the  incidence  of the  causes  were  to  become 
more frequent; (7)  Whereas  Article 129  of  the Treaty 
expressly  provides  for  Community 
competence  in  this  field  insofar  as 
the Community  contributes  by 
encouraging  cooperation  between  the 
Member States and, if  necessary, lending 
support  to  their  action,  promoting 
coordination  of  their  · policies  and 
programmes,  and  fostering  cooperation. 
with  third  countries  and  the  competent 
international organizations in the sphere 
of public  health;  whereas  Community 
action  should  be  directed  towards  the 
prevention of  diseases and the promotion 
of  health education and information; 
(8)  Whereas,  by  helping  to  improve 
knowledge  and  understanding  of rare 
diseases  and  foster  a  wider 
dissemination of  information about them 
and  by  developing  actions 
complementary  to  other  Community 
programmes  and  actions  and  to 
initiatives which are of direct relevance 
to  achievement of the  objective of this 
programme, while avoiding unnecessary 
duplication,  the  programme  will 
contribute  to  the  achievement  of the 
Community  objectives  set  out  in 
Article 129 of  the Treaty; 
(9)  Whereas  an  action programme  on 
rare diseases  should  be  undertaken  as 
part  of  a  coherent  overall  approach 
which  includes  initiatives  in  the  sphere 
of  orphan drugs and medical research; 
(I  0)  Whereas  rare  diseases  have  been 
identified  as  a  priority  area  for 
Community action  in  the  Commission's 
communication  of 24  November  1993 
on the framework for action in the field 
of  public health; 
(I I)  Whereas,  in  its  Resolution  of 
16 January 1996  on  the  Medium-Term 
Social Action Programme  1995-1997 (ll, 
the  European  Parliament  asked  the 
Commission to present, under the proper 
procedures,  the  action programme  for 
rare diseases  provided  for  in  that 
communication; 
<n  OJ C 32, 5.2.1996, p. 24. 
I 
I (12)  Whereas,  in  accordance  with  the 
principle  of  subsidiarity,  action  on 
matters  which  do  not  fall  within  the 
exclusive  competence  of  the 
Community,  such  as  action  on  rare 
diseases,  should  be  undertaken  by  the 
Community  only  if and  insofar  as,  by 
reason  of  its  scale  or  effects,  its 
objectives can be better achieved by the 
Community; 
(13)  Whereas the Community is  in a position 
to provide added value to the actions of 
Member States concerning rare diseases 
through  the  coordination  of  national 
measures,  the  dissemination  of 
information  and  experience,  the  joint 
establishment  of  priorities,  the 
development  of  networking 
as appropriate,  selection  of 
Community-wide  projects  and  the 
motivation  and  mobilization  of  all 
involved; 
(14)  Whereas  cooperation  with  international 
organizations competent in the sphere of 
public  health,  in particular  the  World 
Health  Organization (WHO),  and  with 
third countries, should be fostered; 
(13) Whereas the Community is in a position to 
provide added value to the actions of Member 
States  concerning  rare  diseases  through  the 
coordination  of  national  measures,  the 
dissemination  of information  and  experience, 
the  joint  establishment  of  priorities,  the 
development of networking as appropriate, the 
selection of Community-wide projects and the 
motivation and mobilization of all involved, in 
particular health professionals and patients' and 
support group associations"; 
(13a)  Whereas  the  Council  resolution  on 
equality  of  opportunity  for  ·  people  with 
disabilities  of 20 December  1996  invites  to 
promote the involvement of representatives of 
people with ·disabilities in  the  implementation 
and follow-up of relevant policies and actions 
in their favour; 
(14a)  Whereas  the  high  level  of technology 
currently available can contribute significantly 
to  the  acquisition  of better  knowledge  and 
understanding of, and  the  wider dissemination 
of information  about  rare  diseases,  as  stated 
above,  and whereas this technology should be 
used  to  enhance  the  achievement  of  the 







I (15)  Whereas  the  sysrematic  collection  of 
health data  is  carried out  within  the 
framework  of  the  programme  of 
Community action on health monitoring 
(1997  to  2001)  adopted  by  Decision 
No 1400/97/EC of  the  European 
Parliament  and  of  the  Council  (I); 
whereas  a  regular  exchange  of 
information  and  data must therefore  be 
ensured  between  this  programme  and 
that programme of  Community action on 
health monitoring; 
( 16)  Whereas this programme should last five 
years in order to allow sufficient time to 
implement  measures  to  achieve  the 
objectives set; 
(17)  Whereas,  in  order to  increase the value 
and  impact  of the  programme,  there 
should be continuous assessment of the 
measures taken, with particular regard to 
their effectiveness  and  the  achievement 
of  the objectives set; 
(18)  Whereas  it should be possible to  adjust 
or modify this programme in the light of 
its  evaluation and of any  developments 
that  may  take  place  in  the  general 
context  of the  Community  framework 
for action in the field of  public health; 
( 19)  Whereas  the  introduction  of  specific 
Community arrangements should help to 
ensure  that  Member States  are  swiftly 
informed in the  event of an  emergency 
situation,  so  that  the  protection  of the 
population can be ensured; 
(20)  Whereas  these  Community 
(21) 
(I) 
arrangements for the rapid exchange of 
information will not affect the Member 
States'  rights  and  obligations  under 
treaties  or  bilateral  and  multilateral 
conventions; 
Whereas  it  is  important  that 
the Commission  should  ensure 
implementation  of this  programme  in 
close  cooperation  with  the 
Member States; 
OJ L 193, 22.7.1997, p.  l. 
I 
I (22)  Whereas a modus vivendi <tl between the 
European Parliament,  the Council  and 
the Commission  concerning  the 
implementing measures for acts adopted 
in accordance  with  the  procedure  laid 
down  in  Article 189b of the Treaty was 
reached on 20 December 1994; 
(23)  Whereas  this  Decision  lays  down,  for 
the entire duration of the programme, a 
fmancial  framework  constituting  the 
principal point of reference, within the 
meaning of point 1 of the  Declaration 
of  the European Parliament, the Council 
and  the Commission  of 
6 March 1995 < 2>,  for  the  budgetary 
authority  during  the  annual  budgetary 
procedure, 
HAVE DECIDED AS FOLLOWS: 
Article 1 
Duration and aim of  the programme 
A  programme  of Community  action  on  rare 
diseases,  hereinafter  referred  to  as 
"this programme",  is  hereby  adopted  for  the 
period  from  l January 1999  to 
31  December 2003  within  the  framework  for 
action in the field of  public health. 
The aim of this programme is to contribute,  in 
coordination with  other Community measures, 
towards  insuring  a  high  level  of  health 
protection  in  relation  to  rare  diseases  by 
facilitating  access  to  information  about  these 
diseases,  in  particular for health professionals, 
researchers  and  for  those  affected  directly  or 
indirectly  by  these  diseases,  by  encouraging 
cross-border cooperation of voluntary  support 
groups for the last mentioned and by ensuring 
optimum handling of  clusters. 
The  actions  to  be  implemented  under  this 
programme are set out in the Annex. 
OJ C 102, 4.4.1996, p.  1. 
OJ C 102, 4.4.1996, p. 4. 
Article I 
Duration and aim of  the programme 
The aim of this programme is to contribute, in 
coordination with other Community measures, 
towards  insuring  a  high  level  of  health 
protection  in  relation  to  rare  diseases  by 
improving  knowledge  about  and  facilitating 
access  to  information  about rare  diseases,  in 
particular for .health professionals, researchers, 
and for those affected directly or indirectly by 
these  diseases,  by  encouraging  and 
strengthening  transnational  cooperation  of 
voluntary support groups for the last mentioned 
and by ensuring optimum handling of clusters 
and by fostering the setting up of a system of 
surveillance for rare  diseases  so· that  a  rapid 
and effective response can be made; 















The Commission  shall  ensure  implementation 
of the  actions  set out in  the  Annex  in  close 
cooperation  with  the  Member  States, 
in accordance with ArticleS. 
The Commission  shall  cooperate  with 
institutions and organizations active in the field 
of  rare diseases. 
Article 3 
Consistency and complementarity 
The  Commission  shall  ensure  that  there  is 
consistency and complementarity between the 
actions  to  be  implemented  under  this 
programme and with those implemented under 
other  Community  programmes  and  actions, 
in particular in the sphere of public health, on 
the one hand,  and initiatives in  the sphere of 




The  fmancial  framework  for  the 
implementation  of  this  programme  for  the 
period referred to in  Article 1 is hereby set at 
ECU 6,5 million. 
The annual  appropriations shall be authorized 
by the budgetary authority within the limits of 
the fmancial perspective. 
ArticleS 
Committee 
The Commission  shall  be  assisted  by  a 
Committee consisting of  two representatives of 
each  Member  State  and  chaired  by  a 
representative of  the Commission. 
The  representative  of the Commission  shall 
submit  to  the  Committee  a  draft  of  the 
measures to be taken concerning: 
Article 2 
Implementation 
The Commission shall ensure implementation 
of the  actions  set out in  the  Annex  in close 
cooperation with the Member States. 
Article S 
Committee 
In  implementing  this  Action  Plan,  the 
Commission  shall be assisted by an advisory 
committee,  hereinafter  referred  to  as  "the 
Committee" consisting of representatives from 
each  Member  State,  and  chaired  by  the 
representative of  the Commission. 
The  representative  of the  Commission  shall 
submit  to  the  Committee  a  draft  of  the 















I (a)  the Committee's rules of  procedure; 
(b)  an annual work programme indicating the 
priorities for action; 
(c)  the arrangements, criteria and procedures 
for selecting and fmancing projects under 
this programme, including those involving 
cooperation  with  international 
organizations competent in the sphere of 
public  health  and  participation  of  the 
countries referred to in Article 6(2); 
(d)  the evaluation procedure; 
(e)  the  arrangements  for  dissemination  and 
transfer of  results; 
(f)  the  procedures  for  coordination  with 
programmes and  initiatives  which  are  of 
direct relevance to achievement of  the aim 
of  this programme; 
(g)  the arrangements for cooperating with the 
institutions  and  organisations  referred .  to 
in Article 2{2). 
The Committee shall deliver its opinion on the 
draft measures referred to above within a time 
limit  which  the  Chairman  may  lay  down 
according  to the  urgency  of the  matter.  The 
opinion shall be delivered by the majority laid 
down in Article 148(2) of the Treaty in the case 
of decisions  which  the  Council  is required  to 
adopt on a proposal from the Commission.  The 
votes  of  the  representatives  of  the 
Member States within  the Committee shall be 
weighted in the manner set out in that Article. 
The Chairman shall not vote. 
The  Commission  shall  adopt  measures  which 
shall  apply  immediately.  However,  if these 
measures  are  not  in  accordance  with  the 
opinion  of  the  Committee,  they  shall  be 
communicated  by  the  Commission  to  the 
Council forthwith.  In that event: 
a)  the criteria, and procedures for selecting 
and  fmancing  projects  under  this 
programme; 
b)  the evaluation procedure 
The Committee shall  deliver its  opinion  on 
the  draft,  within  a  time  limit  which  the 
chairperson may  lay  down according to the 
urgency of  the matter if  necessary by taking a 
vote. 
The opinion shall be recorded in the minutes; 
in addition, each Member state shall have the 
right to· ask to have its position recorded in 
the minutes. 
The  Commission  shall  take  the  utmost 
account  of the  opinion  delivered  by  the 
Committee.  It shall inform the Committee of 
the  manner  in  which  its  opinion  has  been 
taken into account. 
The  representative of the Commission shall 
keep  the  Committee  regularly  informed  of 
programmes in  other policy areas which are 
relevant to the achievement of the objectives 














I the Commission shall defer application of 
the  measures which  it  has  decided  upon 
for a period of two months from  the date 
of  such communication; 
the Council,  acting  by  a  qualified 
majority,  may  take  a  different  decision 
within  the  time  limit  laid  down  in  the 
· preceding indent. 
In addition,  the  Commission  may  consult  the 
Committee on any other matter concerning the 
implementation of  this programme. 
The  representative  of the  Commission  shall 
submit  to  the  Committee  a  draft  of  the 
measures  to be  taken.  The Committee  shall 
deliver its  opinion on the  draft within  a time 
limit  which  the Chairman  may  lay  down 
according  to  the  urgency  of  the  matter, 
if  necessary by taking a vote. 
The opinion shall be recorded in the minutes; in 
addition,  each  Member State  shall  have  the 
right to ask to have its position recorded in the 
minutes. 
The Commission shall take the utmost account 
of the opinion delivered by the Committee.  It 
shall  inform the Committee of the  manner in 
which its opinion has been taken into account. 
The  representative  of the  Commission  shall 
keep the Committee regularly informed of: 
financial  assistance  granted  under  this 
programme (amount, duration, breakdown 
and beneficiaries); 
Commission  proposals  or  Community 
initiatives  and  the  implementation  of 
programmes in  other fields  which  are of 
direct  relevance  to  achievement  of the 
objective  of this  programme,  so  as  to 
ensure  consistency  and  complementarity 






















I Article 6 
International cooperation 
Subject  to  Article 228  of the Treaty,  in  the 
course  of  implementing  'this  programme, 
cooperation  with  third  countries  and  with 
international  organizations  competent  in  the 
sphere of public health, in particular the World 
Health  Organization  (WHO},  shall  be 
encouraged  and  implemented  as  regards  the 
actions  covered  by  this  programme  in 
accordance  with  the  procedure  laid down  in 
Article 5. 
This programme shall be open to participation 
by  the  associated  countries of central Europe, 
in accordance with the conditions laid down  in 
the  Association  Agreements  or  Additional 
Protocols  relating  thereto  concerning 
participation in Community programmes. 
This programme shall be open to participation 
by Cyprus and Malta on the basis of additional 
appropriations  in accordance  with  the  same 
rules as  those  applied  to  the  countries of the 
European  Free  Trade  Association  (EFT  A), 
in accordance  with  procedures  to  be  agreed 
with those two countries. 
Article 7 
Monitoring and evaluation 
In  the  implementation  of  this  Decision, 
the Commission  shall  take  the  necessary 
measures  to  ensure  the  monitoring  and 
continuous  evaluation  of  this  programme, 
taking account of  the aim set out in Article 1. 
The Commission shall submit an  interim report 
to  the European Parliament and to the Council 
during the third year of this programme and a 
fmal  report  upon  completion  of  this 
programme.  It shall incorporate into these two 
reports information on Community financing in 
the various fields of action and on consistency 
and  complementarity  with  the  other  actions 
referred to in Article 3, as well as the results of 
the evaluation referred to in paragraph I of this 
Article.  The reports shall also be submitted to 
the  Economic  and  Social Committee  and  the 
Committee of the Regions.  The interim report 
should  also· take  account  of  developments 
occurring within the framework for Community 
action in the field of  public health. 
Article 6 
International cooperation 
1.  In  the  course  of  implementing  this 
programme, cooperation with third countries 
and  with  international  organisations 
competent in  the sphere of public health,  in 
particular  the  World  Health  Organisation 
(WHO),  shall  be  encouraged  and 
implemented as regards  the  actions  covered 



















On the basis of the interim report referred to in 
paragraph 2, the Commission may, ifnecessary. 
make  appropriate  proposals  for  modifications 
or adjustments to this programme. 
DoneatLuxembour& 






Promote the development of, and access 
to,  a European information network on 
rare  diseases,  using  the  existing 
databases  whenever  possible.  The 
information is to comprise entries listing 
the disease  name,  synonyms,  a general 
description  of the  disorder,  symptoms, 
causes, epidemiological data, preventive 
measures,  standard  treatments,  clinical 
trials,  diagnostic  laboratories  and 
specialized  consultations,  research 
programmes  and  a  list  of sources  that 
can be contacted for further information 
about the condition.  The availability of 
this  information  should  be  made  as 
widely known as possible. 
2.  Encourage and support the drawing up 
of  recommendations by professionals in 
order  to  improve  early  detection, 
recognition, intervention and prevention 
in the field of  rare diseases. 
3. 
4. 
Promote  cross-border collaboration and 
networking  between  groups  of persons 
directly  or  indirectly  affected  by  the 
same  rare  conditions  or volunteers  and 
professionals involved and coordination 
at  Community  level  in  order  to 
encourage  continuity  of  work  and 
transnational cooperation. 
Support  at  Community  level  the 
monitoring  of  rare  diseases  in  the 
Member States  and  early  warning 
systems  for  clusters,  and  stimulate  the 
networking  and  training  of  experts 
concerned  with  the  handling  of  rare 
diseases and their clusters. 
,, 
1. Promote the development of, and access 
to, a European information network on rare 
diseases,  using  the  existing  . databases 
among other things.  The information is to 
comprise  entries  listing  the  disease  name, 
synonyms,  a  general  description  of the 
disorder,  symptoms,  causes, 
epidemiological data, preventive measures, 
standard  treatments,  clinical  trials, 
diagnostic  laboratories  and  specialised 
consultations,  research  programmes  and  a 
list  of sources  that  can  be  contacted  for 
further  information  about  the  condition. 
This information should be made as widely 
available as possible. 
3.  Promote  collaboration  and  networking 
·between  groups  of  . persons  directly  or 
indirectly  affected  by  the  same  rare 
conditions or volunteers  and professionals 
involved  and  coordination  at  Community 
level  in  order  to  encourage  continuity  of 
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